{"id": "article-90_0", "title": "Central Line\u2013Associated Blood Stream Infections -- Continuing Education Activity", "content": "A central line-associated bloodstream infection (CLABSI)\u00a0is\u00a0defined\u00a0as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection. Most cases are preventable with proper aseptic techniques, surveillance, and management strategies. This activity describes the evaluation and management of patients undergoing central line placement and highlights the role of the interprofessional team in improving care for affected patients.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Continuing Education Activity. A central line-associated bloodstream infection (CLABSI)\u00a0is\u00a0defined\u00a0as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection. Most cases are preventable with proper aseptic techniques, surveillance, and management strategies. This activity describes the evaluation and management of patients undergoing central line placement and highlights the role of the interprofessional team in improving care for affected patients."}
{"id": "article-90_1", "title": "Central Line\u2013Associated Blood Stream Infections -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of CLABSI. Review key history and physical exam findings of patients with CLABSI. Summarize the treatment options for CLABSI. Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by CLABSI. Access free multiple choice questions on this topic.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Continuing Education Activity. Objectives: Describe the pathophysiology of CLABSI. Review key history and physical exam findings of patients with CLABSI. Summarize the treatment options for CLABSI. Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by CLABSI. Access free multiple choice questions on this topic."}
{"id": "article-90_2", "title": "Central Line\u2013Associated Blood Stream Infections -- Introduction", "content": "A central line-associated bloodstream infection (CLABSI)\u00a0is defined\u00a0as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection.\u00a0Of all the healthcare-associated infections, CLABSIs are associated with a high-cost burden, accounting for approximately $46,000 per case. Most cases\u00a0are preventable with proper aseptic techniques, surveillance, and management strategies. [1] [2]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Introduction. A central line-associated bloodstream infection (CLABSI)\u00a0is defined\u00a0as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection.\u00a0Of all the healthcare-associated infections, CLABSIs are associated with a high-cost burden, accounting for approximately $46,000 per case. Most cases\u00a0are preventable with proper aseptic techniques, surveillance, and management strategies. [1] [2]"}
{"id": "article-90_3", "title": "Central Line\u2013Associated Blood Stream Infections -- Etiology", "content": "Based on the National Healthcare Safety Network (NHSN) data from January 2006 to October 2007, the order of selected pathogens associated with causing CLABSI is as follows. Gram-positive organisms (coagulase-negative staphylococci ,\u00a034.1%; enterococci ,\u00a016%; and Staphylococcus aureus ,\u00a09.9%) are the most common, followed by gram-negatives ( Klebsiella ,\u00a05.8%; Enterobacter ,\u00a03.9%; Pseudomonas ,\u00a03.1%; E. coli ,\u00a02.7%; Acinetobacter ,\u00a02.2%), Candida species\u00a0(11.8%), and others (10.5%). [3] [4]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Etiology. Based on the National Healthcare Safety Network (NHSN) data from January 2006 to October 2007, the order of selected pathogens associated with causing CLABSI is as follows. Gram-positive organisms (coagulase-negative staphylococci ,\u00a034.1%; enterococci ,\u00a016%; and Staphylococcus aureus ,\u00a09.9%) are the most common, followed by gram-negatives ( Klebsiella ,\u00a05.8%; Enterobacter ,\u00a03.9%; Pseudomonas ,\u00a03.1%; E. coli ,\u00a02.7%; Acinetobacter ,\u00a02.2%), Candida species\u00a0(11.8%), and others (10.5%). [3] [4]"}
{"id": "article-90_4", "title": "Central Line\u2013Associated Blood Stream Infections -- Etiology", "content": "Tunneled hemodialysis catheters are prone to CRBSIs. Approximately 40%\u201380% of CRBSIs are caused by gram-positive organisms. Coagulase-negative Staphylococci, Staphylococcus aureus, and Enterococcus are the most common organisms. Methicillin-resistant staphylococcus is frequently seen. 20%\u201330% of infections CRBSIs are\u00a0caused by gram-negative organisms [5] .", "contents": "Central Line\u2013Associated Blood Stream Infections -- Etiology. Tunneled hemodialysis catheters are prone to CRBSIs. Approximately 40%\u201380% of CRBSIs are caused by gram-positive organisms. Coagulase-negative Staphylococci, Staphylococcus aureus, and Enterococcus are the most common organisms. Methicillin-resistant staphylococcus is frequently seen. 20%\u201330% of infections CRBSIs are\u00a0caused by gram-negative organisms [5] ."}
{"id": "article-90_5", "title": "Central Line\u2013Associated Blood Stream Infections -- Epidemiology", "content": "CLABSIs\u00a0lead to prolonged hospital stays and increase healthcare costs\u00a0and mortality. An estimated 250,000 bloodstream infections occur annually, and most are related to the presence of\u00a0intravascular devices. In the United States, the CLABSI rate in intensive care units (ICU) is estimated to be 0.8 per 1000 central line days. International Nosocomial Infection Control Consortium (INICC) surveillance data from January 2010 through December 2015 (703 intensive care units in 50 countries) reported a CLABSI rate of 4.1 per 1000 central line days. Many central lines are found outside the ICUs. In one study, 55% of ICU and 24% of non-ICU patients had central lines. However, as more patients are located outside the ICU, 70% of hospitalized patients with central venous catheters were outside the ICU. [6] .\u00a0In recent years, peripherally inserted central catheters (PICCs) have increased significantly, given some inherent\u00a0advantages these devices offer [7] . Trained nursing staff can place PICC lines at the bedside with ultrasound guidance, allowing quick central venous access in both ICUs and general medical wards. Since PICCs are inserted in a peripheral vein of the arm with the tip advanced into a central vein (cavoatrial junction or the right atrium) by definition,\u00a0they\u00a0are central venous catheters. See Image. Central Venous Catheterization Body Access. The rates of CLABSI associated with PICCs are statistically similar to the conventional central venous catheters (CVCs) in the hospital setting [8] . In a multicenter study of 27,289 patients, CLABSI outcomes between the PICCs placed in the ICU compared to the general medical ward were\u00a0similar. However, the study was limited, with an overall low number of events [9] .", "contents": "Central Line\u2013Associated Blood Stream Infections -- Epidemiology. CLABSIs\u00a0lead to prolonged hospital stays and increase healthcare costs\u00a0and mortality. An estimated 250,000 bloodstream infections occur annually, and most are related to the presence of\u00a0intravascular devices. In the United States, the CLABSI rate in intensive care units (ICU) is estimated to be 0.8 per 1000 central line days. International Nosocomial Infection Control Consortium (INICC) surveillance data from January 2010 through December 2015 (703 intensive care units in 50 countries) reported a CLABSI rate of 4.1 per 1000 central line days. Many central lines are found outside the ICUs. In one study, 55% of ICU and 24% of non-ICU patients had central lines. However, as more patients are located outside the ICU, 70% of hospitalized patients with central venous catheters were outside the ICU. [6] .\u00a0In recent years, peripherally inserted central catheters (PICCs) have increased significantly, given some inherent\u00a0advantages these devices offer [7] . Trained nursing staff can place PICC lines at the bedside with ultrasound guidance, allowing quick central venous access in both ICUs and general medical wards. Since PICCs are inserted in a peripheral vein of the arm with the tip advanced into a central vein (cavoatrial junction or the right atrium) by definition,\u00a0they\u00a0are central venous catheters. See Image. Central Venous Catheterization Body Access. The rates of CLABSI associated with PICCs are statistically similar to the conventional central venous catheters (CVCs) in the hospital setting [8] . In a multicenter study of 27,289 patients, CLABSI outcomes between the PICCs placed in the ICU compared to the general medical ward were\u00a0similar. However, the study was limited, with an overall low number of events [9] ."}
{"id": "article-90_6", "title": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology", "content": "Central lines are of\u00a0two types: (1) Tunneled catheters are implanted surgically (by creating a subcutaneous track before entering the vein) into the internal jugular, subclavian, or femoral vein for long-term (weeks to months) use such as chemotherapy or hemodialysis and (2) Non-tunneled catheters, more commonly used. They are temporary central venous catheters inserted percutaneously and account for most CLABSIs. Within 7 to 10 days of central venous catheter placement, bacteria on the skin surface migrate along the external surface of the catheter from the skin exit site towards the intravascular space. Typically, tunneled catheters have a cuff that causes a fibrotic reaction around the catheter, creating\u00a0a barrier to bacterial migration). The absence of a tunnel (a subcutaneous tract) places non-tunneled catheters at higher risk for CLABSIs. CLABSIs that occur beyond ten days are\u00a0usually caused by\u00a0contamination of the hub (intraluminal), typically from a health care provider's contaminated hands but rarely from a host and often due to a\u00a0breach of standard aseptic precautions to access the hub. Less common mechanisms include hematogenous seeding of bacteria from a contaminated infusate or another source.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology. Central lines are of\u00a0two types: (1) Tunneled catheters are implanted surgically (by creating a subcutaneous track before entering the vein) into the internal jugular, subclavian, or femoral vein for long-term (weeks to months) use such as chemotherapy or hemodialysis and (2) Non-tunneled catheters, more commonly used. They are temporary central venous catheters inserted percutaneously and account for most CLABSIs. Within 7 to 10 days of central venous catheter placement, bacteria on the skin surface migrate along the external surface of the catheter from the skin exit site towards the intravascular space. Typically, tunneled catheters have a cuff that causes a fibrotic reaction around the catheter, creating\u00a0a barrier to bacterial migration). The absence of a tunnel (a subcutaneous tract) places non-tunneled catheters at higher risk for CLABSIs. CLABSIs that occur beyond ten days are\u00a0usually caused by\u00a0contamination of the hub (intraluminal), typically from a health care provider's contaminated hands but rarely from a host and often due to a\u00a0breach of standard aseptic precautions to access the hub. Less common mechanisms include hematogenous seeding of bacteria from a contaminated infusate or another source."}
{"id": "article-90_7", "title": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology", "content": "Host factors that increase the risk of CLABSI are chronic illnesses (hemodialysis, malignancy, gastrointestinal tract disorders, pulmonary hypertension), immune-suppressed states (organ transplant, diabetes mellitus), malnutrition, total parenteral nutrition, extremes of age, loss of skin integrity (burns) and prolonged hospitalization before line insertion.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology. Host factors that increase the risk of CLABSI are chronic illnesses (hemodialysis, malignancy, gastrointestinal tract disorders, pulmonary hypertension), immune-suppressed states (organ transplant, diabetes mellitus), malnutrition, total parenteral nutrition, extremes of age, loss of skin integrity (burns) and prolonged hospitalization before line insertion."}
{"id": "article-90_8", "title": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology", "content": "Femoral central venous catheters are associated with the highest risk of CLABSI, followed by internal jugular and subclavian catheters. Further, the catheter type, insertion conditions (emergent versus\u00a0elective, use of full barrier precautions versus limited), catheter care, and operator skill also influence the risk of CLABSI.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology. Femoral central venous catheters are associated with the highest risk of CLABSI, followed by internal jugular and subclavian catheters. Further, the catheter type, insertion conditions (emergent versus\u00a0elective, use of full barrier precautions versus limited), catheter care, and operator skill also influence the risk of CLABSI."}
{"id": "article-90_9", "title": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology", "content": "Pseudomonas is commonly associated with\u00a0neutropenia, severe illness, or known prior colonization. Candida is associated with risk factors: femoral catheterization,\u00a0TPN, prolonged administration of broad-spectrum antibiotics, hematologic malignancy, or solid organ or hematopoietic stem cell transplantation. Certain bacteria such as staphylococci, Pseudomonas, and Candida produce extracellular polysaccharide [slime (biofilm)], which favors increased virulence, adherence to catheter surface, and resistance to antimicrobial therapy. [10]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pathophysiology. Pseudomonas is commonly associated with\u00a0neutropenia, severe illness, or known prior colonization. Candida is associated with risk factors: femoral catheterization,\u00a0TPN, prolonged administration of broad-spectrum antibiotics, hematologic malignancy, or solid organ or hematopoietic stem cell transplantation. Certain bacteria such as staphylococci, Pseudomonas, and Candida produce extracellular polysaccharide [slime (biofilm)], which favors increased virulence, adherence to catheter surface, and resistance to antimicrobial therapy. [10]"}
{"id": "article-90_10", "title": "Central Line\u2013Associated Blood Stream Infections -- History and Physical", "content": "Clinical manifestations vary depending on the severity of the illness. Fever and chills are the most common manifestations. Still, they may be\u00a0masked if the patient is immunocompromised or at extremes of an age where atypical presentations of sepsis occur (altered mental status, hypotension, lethargy, fatigue). Exit site examination to look for signs of inflammation\u00a0of tunneled catheters with inspection and palpation of the subcutaneous track is essential. Patients may report pain, swelling, or discharge from the exit site and redness surrounding or along the subcutaneous track when exit site or tunnel infections are present. For long-term catheters, difficulty drawing blood or poor flow are\u00a0considered\u00a0risk factors and manifestations of CLABSI.", "contents": "Central Line\u2013Associated Blood Stream Infections -- History and Physical. Clinical manifestations vary depending on the severity of the illness. Fever and chills are the most common manifestations. Still, they may be\u00a0masked if the patient is immunocompromised or at extremes of an age where atypical presentations of sepsis occur (altered mental status, hypotension, lethargy, fatigue). Exit site examination to look for signs of inflammation\u00a0of tunneled catheters with inspection and palpation of the subcutaneous track is essential. Patients may report pain, swelling, or discharge from the exit site and redness surrounding or along the subcutaneous track when exit site or tunnel infections are present. For long-term catheters, difficulty drawing blood or poor flow are\u00a0considered\u00a0risk factors and manifestations of CLABSI."}
{"id": "article-90_11", "title": "Central Line\u2013Associated Blood Stream Infections -- Evaluation", "content": "In addition to the clinical exam, lab investigations are essential for diagnosis and management. Blood culture is the most crucial step towards diagnosis, in addition, to complete blood count, serum electrolytes, and renal and liver function tests, which are necessary to assess for severity and co-morbidities. In suspected cases, paired blood cultures (one from the central line and peripheral vein) must be drawn and labeled accordingly before being sent to the lab. In the case of poor peripheral access or when unable to obtain a peripheral sample, two or more samples must be drawn from different lumens of a multi-lumen central line. The following definitions help in arriving at a diagnosis:", "contents": "Central Line\u2013Associated Blood Stream Infections -- Evaluation. In addition to the clinical exam, lab investigations are essential for diagnosis and management. Blood culture is the most crucial step towards diagnosis, in addition, to complete blood count, serum electrolytes, and renal and liver function tests, which are necessary to assess for severity and co-morbidities. In suspected cases, paired blood cultures (one from the central line and peripheral vein) must be drawn and labeled accordingly before being sent to the lab. In the case of poor peripheral access or when unable to obtain a peripheral sample, two or more samples must be drawn from different lumens of a multi-lumen central line. The following definitions help in arriving at a diagnosis:"}
{"id": "article-90_12", "title": "Central Line\u2013Associated Blood Stream Infections -- Evaluation", "content": "Catheter-related bloodstream infection (CRBSI) - Infectious Diseases Society of America (IDSA) definition: Catheter-related bloodstream infection (CRBSI) is the preferred term used by IDSA. The definite diagnosis of CRBSI requires\u00a0one of the following: Isolation of the same pathogen from a quantitative blood culture drawn through the central line\u00a0and from a peripheral vein with the single bacterial colony count at least threefold higher in the sample from the central line as compared to that obtained from a peripheral vein (or) same organism recovered from percutaneous blood culture and quantitative (>15 colony-forming units) culture of the catheter tip (or) a\u00a0shorter time to positive culture (>2 hours earlier) in the central line sample\u00a0than the peripheral sample (differential time to positivity [\u00a0DTP\u00a0]) [11]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Evaluation. Catheter-related bloodstream infection (CRBSI) - Infectious Diseases Society of America (IDSA) definition: Catheter-related bloodstream infection (CRBSI) is the preferred term used by IDSA. The definite diagnosis of CRBSI requires\u00a0one of the following: Isolation of the same pathogen from a quantitative blood culture drawn through the central line\u00a0and from a peripheral vein with the single bacterial colony count at least threefold higher in the sample from the central line as compared to that obtained from a peripheral vein (or) same organism recovered from percutaneous blood culture and quantitative (>15 colony-forming units) culture of the catheter tip (or) a\u00a0shorter time to positive culture (>2 hours earlier) in the central line sample\u00a0than the peripheral sample (differential time to positivity [\u00a0DTP\u00a0]) [11]"}
{"id": "article-90_13", "title": "Central Line\u2013Associated Blood Stream Infections -- Evaluation", "content": "CLABSI\u00a0-\u00a0Centers for Disease Control and Prevention (CDC) definition : CLABSI is a surveillance definition used by the CDC and defined\u00a0as the recovery of a pathogen from a blood culture (a single blood culture for an organism not commonly present on the skin and two or more blood cultures for organism commonly present on the skin) in a patient who had a central line at the time of infection or within 48 hours before the development of infection. The infection cannot be related to any other infection the patient might have and must not have been present or incubating when the patient was admitted to the facility. [4] In the case of tunneled catheters, the accepted definitions for exit site and tunnel infections are\u00a0as follows: Exit site infection: Signs of inflammation confined to an area (typically < 2 cm) surrounding the catheter exit site and the presence of\u00a0exudate that proves to be culture-positive.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Evaluation. CLABSI\u00a0-\u00a0Centers for Disease Control and Prevention (CDC) definition : CLABSI is a surveillance definition used by the CDC and defined\u00a0as the recovery of a pathogen from a blood culture (a single blood culture for an organism not commonly present on the skin and two or more blood cultures for organism commonly present on the skin) in a patient who had a central line at the time of infection or within 48 hours before the development of infection. The infection cannot be related to any other infection the patient might have and must not have been present or incubating when the patient was admitted to the facility. [4] In the case of tunneled catheters, the accepted definitions for exit site and tunnel infections are\u00a0as follows: Exit site infection: Signs of inflammation confined to an area (typically < 2 cm) surrounding the catheter exit site and the presence of\u00a0exudate that proves to be culture-positive."}
{"id": "article-90_14", "title": "Central Line\u2013Associated Blood Stream Infections -- Evaluation", "content": "Tunnel infection:  Inflammation extending beyond 2 cm from the exit site (along with the track or cephalad towards the vein entry site or extending beyond the cuff), typically associated with pain and tenderness along the subcutaneous track and culture-positive exudate at the exit site that may not be seen unless expressed by palpation.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Evaluation. Tunnel infection:  Inflammation extending beyond 2 cm from the exit site (along with the track or cephalad towards the vein entry site or extending beyond the cuff), typically associated with pain and tenderness along the subcutaneous track and culture-positive exudate at the exit site that may not be seen unless expressed by palpation."}
{"id": "article-90_15", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "When CLABSI is suspected, empiric therapy should be based on the most likely organism, host factors, and the overall clinical picture. While awaiting cultures, empiric treatment should be instituted promptly. In general, coverage for common gram-positive and gram-negative organisms is necessary. The\u00a0local prevalence and antimicrobial susceptibility patterns in institutional antibiograms should be considered. The following are some\u00a0considerations.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. When CLABSI is suspected, empiric therapy should be based on the most likely organism, host factors, and the overall clinical picture. While awaiting cultures, empiric treatment should be instituted promptly. In general, coverage for common gram-positive and gram-negative organisms is necessary. The\u00a0local prevalence and antimicrobial susceptibility patterns in institutional antibiograms should be considered. The following are some\u00a0considerations."}
{"id": "article-90_16", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "Parenteral vancomycin if methicillin-resistant staphylococci\u00a0(MRSA)\u00a0is prevalent. Otherwise, parenteral anti-staphylococcal penicillin or cephalosporins such as nafcillin or cefazolin would suffice. If MRSA isolates, exhibit a minimum inhibitory concentration of > 2 mg/mL for vancomycin or, in the case of vancomycin-resistant enterococci (VRE), daptomycin is the drug of choice.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. Parenteral vancomycin if methicillin-resistant staphylococci\u00a0(MRSA)\u00a0is prevalent. Otherwise, parenteral anti-staphylococcal penicillin or cephalosporins such as nafcillin or cefazolin would suffice. If MRSA isolates, exhibit a minimum inhibitory concentration of > 2 mg/mL for vancomycin or, in the case of vancomycin-resistant enterococci (VRE), daptomycin is the drug of choice."}
{"id": "article-90_17", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "The antibiotic choice for gram-negative coverage should be based on the risk of pseudomonal infection and local susceptibility patterns. If the risk of Pseudomonas is low, then a third-generation cephalosporin such as ceftriaxone is appropriate. In patients with a critical illness or high risk for resistant organisms, a combination of a beta-lactam (lactamase inhibitor) and an aminoglycoside is preferred - Cefepime or carbapenem with or without an aminoglycoside. Agents against Pseudomonas aeruginosa are required\u00a0in the setting of neutropenia, severe illness, or known prior colonization.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. The antibiotic choice for gram-negative coverage should be based on the risk of pseudomonal infection and local susceptibility patterns. If the risk of Pseudomonas is low, then a third-generation cephalosporin such as ceftriaxone is appropriate. In patients with a critical illness or high risk for resistant organisms, a combination of a beta-lactam (lactamase inhibitor) and an aminoglycoside is preferred - Cefepime or carbapenem with or without an aminoglycoside. Agents against Pseudomonas aeruginosa are required\u00a0in the setting of neutropenia, severe illness, or known prior colonization."}
{"id": "article-90_18", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "Echinocandins (micafungin, caspofungin, anidulafungin) are preferred agents for suspected candidemia if azole resistance is suspected (prior azole use or prevalent nonalbicans candida such as C.glabrata or C.krusei ). Otherwise, intravenous fluconazole would suffice. Antifungal therapy must be considered in femoral catheterization, TPN, prolonged administration of broad-spectrum antibiotics, hematologic malignancy, or solid organ or bone marrow transplant recipients.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. Echinocandins (micafungin, caspofungin, anidulafungin) are preferred agents for suspected candidemia if azole resistance is suspected (prior azole use or prevalent nonalbicans candida such as C.glabrata or C.krusei ). Otherwise, intravenous fluconazole would suffice. Antifungal therapy must be considered in femoral catheterization, TPN, prolonged administration of broad-spectrum antibiotics, hematologic malignancy, or solid organ or bone marrow transplant recipients."}
{"id": "article-90_19", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "Once antimicrobial susceptibility results are available, de-escalation to specific and appropriate therapy is recommended.\u00a0If blood cultures have no growth, the need for further empiric antibiotic treatment should be reassessed. Suppose unexplained fever or sepsis persisted in a patient with a short-term central\u00a0venous or arterial catheter and paired peripheral venipuncture and catheter blood cultures have failed to identify CLABSI. In that case, the catheter should be removed,\u00a0and the tip should be sent for culture.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. Once antimicrobial susceptibility results are available, de-escalation to specific and appropriate therapy is recommended.\u00a0If blood cultures have no growth, the need for further empiric antibiotic treatment should be reassessed. Suppose unexplained fever or sepsis persisted in a patient with a short-term central\u00a0venous or arterial catheter and paired peripheral venipuncture and catheter blood cultures have failed to identify CLABSI. In that case, the catheter should be removed,\u00a0and the tip should be sent for culture."}
{"id": "article-90_20", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "All non-tunneled catheters causing CLABSI should be removed promptly, sometimes even before it is proven with the above criteria when clinical suspicion is high.\u00a0Only for long-term catheters,\u00a0salvage (systemic therapy coupled with antimicrobial lock [heparin + high concentration of antimicrobial agent that is selected based on susceptibility results]) can be attempted in limited instances such as: Uncomplicated CLABSI is caused by organisms other than Staphylococcus aureus , Pseudomonas aeruginosa , Bacillus spp, Micrococcus species, Propionibacteria, fungi, or mycobacteria. The patients with limited vascular access sites or the ones who are solely dependent on central access for survival.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. All non-tunneled catheters causing CLABSI should be removed promptly, sometimes even before it is proven with the above criteria when clinical suspicion is high.\u00a0Only for long-term catheters,\u00a0salvage (systemic therapy coupled with antimicrobial lock [heparin + high concentration of antimicrobial agent that is selected based on susceptibility results]) can be attempted in limited instances such as: Uncomplicated CLABSI is caused by organisms other than Staphylococcus aureus , Pseudomonas aeruginosa , Bacillus spp, Micrococcus species, Propionibacteria, fungi, or mycobacteria. The patients with limited vascular access sites or the ones who are solely dependent on central access for survival."}
{"id": "article-90_21", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "In the case of tunneled hemodialysis catheters, uncomplicated exit site infections can be treated with short-course topical or systemic antimicrobials. All tunnel infections will require catheter removal due to a high risk of CLABSI. Additional indications for removal of CLABSI from hemodialysis access include: Persistent symptoms > 36 hours or severe sepsis, hemodynamic instability(shock), and metastatic infection. Blood cultures that remain positive > 72 hours of appropriate antimicrobial therapy. Difficult to clear organisms ( S. aureus, Pseudomonas, or fungi). Recurrence of uncomplicated CLABSI (any non-virulent organism) when salvaged for difficult access.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. In the case of tunneled hemodialysis catheters, uncomplicated exit site infections can be treated with short-course topical or systemic antimicrobials. All tunnel infections will require catheter removal due to a high risk of CLABSI. Additional indications for removal of CLABSI from hemodialysis access include: Persistent symptoms > 36 hours or severe sepsis, hemodynamic instability(shock), and metastatic infection. Blood cultures that remain positive > 72 hours of appropriate antimicrobial therapy. Difficult to clear organisms ( S. aureus, Pseudomonas, or fungi). Recurrence of uncomplicated CLABSI (any non-virulent organism) when salvaged for difficult access."}
{"id": "article-90_22", "title": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management", "content": "Duration of therapy : For patients with uncomplicated CRBSI (e.g., no endocarditis, or metastatic infection), in the absence of risk factors for hematogenous spread (e.g., hardware, immunosuppression) and negative blood cultures 72 hours of catheter removal, following approach for intravenous antimicrobial therapy\u00a0is recommended: S. aureus - 14 days in the absence of endocarditis Coagulase-negative staphylococci - 7 days Enterococci and gram-negative bacilli - 10 to 14 days Candida - 14 days in the absence of retinitis", "contents": "Central Line\u2013Associated Blood Stream Infections -- Treatment / Management. Duration of therapy : For patients with uncomplicated CRBSI (e.g., no endocarditis, or metastatic infection), in the absence of risk factors for hematogenous spread (e.g., hardware, immunosuppression) and negative blood cultures 72 hours of catheter removal, following approach for intravenous antimicrobial therapy\u00a0is recommended: S. aureus - 14 days in the absence of endocarditis Coagulase-negative staphylococci - 7 days Enterococci and gram-negative bacilli - 10 to 14 days Candida - 14 days in the absence of retinitis"}
{"id": "article-90_23", "title": "Central Line\u2013Associated Blood Stream Infections -- Differential Diagnosis", "content": "Exit site infections Phlebitis Pocket infections Sepsis Tunnel infections Urinary tract infection", "contents": "Central Line\u2013Associated Blood Stream Infections -- Differential Diagnosis. Exit site infections Phlebitis Pocket infections Sepsis Tunnel infections Urinary tract infection"}
{"id": "article-90_24", "title": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Insertion", "content": "Recent data reveal no difference in the infection rate based on the insertion catheter site. The following are some\u00a0key components of a prevention program, abstracted from an extensive list provided by the CDC and IDSA. [12] [13] [10]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Insertion. Recent data reveal no difference in the infection rate based on the insertion catheter site. The following are some\u00a0key components of a prevention program, abstracted from an extensive list provided by the CDC and IDSA. [12] [13] [10]"}
{"id": "article-90_25", "title": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Insertion", "content": "Hand hygiene by washing hands with soap, water, or alcohol-based gels or foams. Gloves do not prevent the need for hand hygiene. A strict aseptic technique using maximal sterile barrier precautions, including a full-body drape when inserting central venous catheters. Use 2% chlorhexidine skin preparations for disinfecting/ cleaning skin before insertion. Ultrasound guidance by an experienced provider for placement to circumvent mechanical complications and reduce the number of attempts. Avoid the\u00a0femoral vein as a choice for central line placement, and prefer the subclavian vein when possible for non-tunneled catheters. Promptly remove\u00a0any central line that is no longer required. Replace central lines placed during an emergency (asepsis not assured) as soon as possible or within 48 hours. Use a checklist.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Insertion. Hand hygiene by washing hands with soap, water, or alcohol-based gels or foams. Gloves do not prevent the need for hand hygiene. A strict aseptic technique using maximal sterile barrier precautions, including a full-body drape when inserting central venous catheters. Use 2% chlorhexidine skin preparations for disinfecting/ cleaning skin before insertion. Ultrasound guidance by an experienced provider for placement to circumvent mechanical complications and reduce the number of attempts. Avoid the\u00a0femoral vein as a choice for central line placement, and prefer the subclavian vein when possible for non-tunneled catheters. Promptly remove\u00a0any central line that is no longer required. Replace central lines placed during an emergency (asepsis not assured) as soon as possible or within 48 hours. Use a checklist."}
{"id": "article-90_26", "title": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Maintenance", "content": "Disinfect the catheter hubs, injection ports, and connections before accessing the line. Replace administration sets other than sets used for lipids or blood products every 96 hours. Assess\u00a0the need for the central line daily.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Pearls and Other Issues -- Prevention Guidelines During Maintenance. Disinfect the catheter hubs, injection ports, and connections before accessing the line. Replace administration sets other than sets used for lipids or blood products every 96 hours. Assess\u00a0the need for the central line daily."}
{"id": "article-90_27", "title": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes", "content": "Central line-associated bloodstream infection (CLABSI) is a highly prevalent problem in the intensive care unit. These infections are associated with over 28,000 deaths yearly and cost over $2 billion. Only through best practices, protocols, checklists, and establishing a culture of patient safety in healthcare institutions can one reduce CLABSI to zero. [14] One of the significant reasons for central line removal is an infection or suspicion. This clinical practice leads to prolonged hospital stays and increased procedures and complication rates.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes. Central line-associated bloodstream infection (CLABSI) is a highly prevalent problem in the intensive care unit. These infections are associated with over 28,000 deaths yearly and cost over $2 billion. Only through best practices, protocols, checklists, and establishing a culture of patient safety in healthcare institutions can one reduce CLABSI to zero. [14] One of the significant reasons for central line removal is an infection or suspicion. This clinical practice leads to prolonged hospital stays and increased procedures and complication rates."}
{"id": "article-90_28", "title": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes", "content": "One of the challenges with central lines is the variety of catheter types inserted by diverse staff. In many hospitals, central lines are inserted by specialists, including anesthesiologists, surgeons, emergency room physicians, radiologists, and critical care physicians. [15] . PICC lines are often inserted by trained nursing staff. This heterogeneity has resulted in varied outcomes, but infections continue to be a common problem in almost every study. Evidence- Based Medicine", "contents": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes. One of the challenges with central lines is the variety of catheter types inserted by diverse staff. In many hospitals, central lines are inserted by specialists, including anesthesiologists, surgeons, emergency room physicians, radiologists, and critical care physicians. [15] . PICC lines are often inserted by trained nursing staff. This heterogeneity has resulted in varied outcomes, but infections continue to be a common problem in almost every study. Evidence- Based Medicine"}
{"id": "article-90_29", "title": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes", "content": "Over the years, many guidelines have been established; some hospitals have a policy that for long-term access, the line can only be inserted by a\u00a0dedicated team that\u00a0consists of the surgeon, nurses, and a pharmacist who will monitor the patient. In addition, when administering TPN, one port is dedicated to nutrition. Plus, in some units, only nurses with training in central lines are allowed to infuse medications and other solutions. Evidence-based guidelines show that adhering to protocols can reduce the rate of CLABSI. However, audits of doctors who insert the central lines and nurses who monitor the lines for infections are vital to ensure compliance. [10] [Level 3]", "contents": "Central Line\u2013Associated Blood Stream Infections -- Enhancing Healthcare Team Outcomes. Over the years, many guidelines have been established; some hospitals have a policy that for long-term access, the line can only be inserted by a\u00a0dedicated team that\u00a0consists of the surgeon, nurses, and a pharmacist who will monitor the patient. In addition, when administering TPN, one port is dedicated to nutrition. Plus, in some units, only nurses with training in central lines are allowed to infuse medications and other solutions. Evidence-based guidelines show that adhering to protocols can reduce the rate of CLABSI. However, audits of doctors who insert the central lines and nurses who monitor the lines for infections are vital to ensure compliance. [10] [Level 3]"}
{"id": "article-90_30", "title": "Central Line\u2013Associated Blood Stream Infections -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Central Line\u2013Associated Blood Stream Infections -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}